Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC to be Published in European Radiology
September 04, 2018 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...
Delcath Systems to Present at the 8th Annual LD Micro Invitational
May 29, 2018 08:30 ET
|
Delcath Systems, Inc.
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced...
Bile Duct Cancer (Cholangiocarcinoma) Treatment Market to show Incremental Opportunity of US$ 144.2 Mn by 2025 - Persistence Market Research
December 21, 2017 03:32 ET
|
Persistence Market Research
New York City, NY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Persistence Market Research(PMR) forecasts the global bile duct cancer treatment market to grow from about US$ 168 Mn in 2017 to about US$ 312 Mn...